IAVI Skip to content
Back to Main Menu
  • Our Work
    • Research & Development
      • Discovery
      • Epidemiology
      • Clinical Development
      • Product Development 
      • Global Access
      • Advocacy & Community Engagement 
    • Health Areas
      • Pipeline
      • HIV Vaccines 
      • HIV Antibodies 
      • Tuberculosis
      • Emerging Infectious Diseases
  • About
    • About IAVI
      • About IAVI
      • Our Story
      • Careers
      • Diversity, Equity, & Inclusion
      • Financial Statements
      • Contact us
    • Regions
      • Africa
      • Europe
      • India
      • United States
    • Leadership
      • Board of Directors
      • Senior Leadership
    • Funders & Partners
      • Funders
      • Partnerships
  • Media & Resources
    • News & Press
      • Features
      • Press Releases
      • In The News
    • Digital Media
      • Videos
      • Podcasts
    • Resources
      • IAVI Report
      • Scientific Publications
      • Vaccine Literacy Library
      • Fact Sheets & Publications
Search
Close
  • Quick Links
    • Our Work
    • Emerging Infectious Diseases
    • Pipeline
    • Senior Leadership
  • Trending Now
    • HIV Vaccines
    • HIV Antibodies
    • Tuberculosis

The state of vaccine science now is far more powerful and sophisticated than it has ever been. And I am confident that many of these challenges that we face will be solved by vaccine development.

Mark Feinberg

President & CEO

We are a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases.

  • Instagram
  • YouTube
  • Facebook
  • LinkedIn

Quick Links


Careers

HIV Vaccines

HIV Antibodies

Tuberculosis

Emerging Infectious Diseases

Contact Us


IAVI U.S.
125 Broad Street, 9th Floor
New York, NY 10004
T: +1.212.847.1111
F: +1.212.847.1112

Platinum Transparency 2024. Candid.
Four Star Rating Badge 1

Contact us Diversity, Equity, & Inclusion Privacy Policy Terms of Use Compliance & RFPs

©2025 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative®, IAVI®, and the IAVI logo® are registered trademarks of the International AIDS Vaccine Initiative, Inc.

Subscribe

Use this form to receive updates on IAVI‘s work and the latest news from the field.

Subscription Type

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}